Srinivas Sridhar

Srinivas Sridhar is a University Distinguished Professor of Physics, Biomedical Engineering, and Chemical Engineering at Northeastern University, with a secondary appointment as Lecturer on Radiation Oncology at Harvard Medical School. He previously served as Vice Provost for Research at Northeastern University (2004–2008), overseeing its research portfolio. As an elected Fellow of the American Physical Society and the American Institute of Medical and Biological Engineering, his research spans nanomedicine, neurotechnology, drug delivery, and quantitative MRI, with over 450 publications and patents. He founded the Nanomedicine Innovation Center and directs major NIH/NSF programs like CaNCURE and IGERT, focusing on undergraduate and graduate training in nanomedicine, particularly for underrepresented communities.

His research interests include

• Nanomedicine
• Neurotechnology
• Quantitative MRI
• Drug Delivery Systems
• Metamaterials and Nanophotonics
• Quantum Chaos
• Superconductivity

. Recent work involves machine learning-enhanced diagnostics for glaucoma, engineered nanoparticles for BRCA-deficient cancers, and portable neuro-ophthalmic devices. His publications from 2025–2017 reflect interdisciplinary applications in oncology, neurology, and materials science, with a focus on therapeutic and diagnostic innovation.

Scientific accolades include the

• 2016 Biomedical Engineering Society Diversity Award
• University Distinguished Professorship

. As an educator and entrepreneur, he has trained over 120 researchers, developed first-of-their-kind nanomedicine courses, and founded companies commercializing technologies like QUTE-CE MRI. His lab leads projects on cancer nanomedicine, quantitative imaging, and nanoscale magnetism, supported by grants from NIH, NSF, DoD, and private foundations.